Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Trop Pediatr ; 62(2): 158-60, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26721550

RESUMO

BACKGROUND: Results in neonatal screening programs aiming at detection of congenital adrenal hyperplasia (CAH) can only report elevated levels of 17-hydroxy-progesterone (17-OHP), without being able to differentiate presence or absence of salt loss. AIM: To predict presence or absence of salt loss in newborn infants with CAH. METHODS: The first specimen of suspected CAH in samples sent from People's Democratic Republic of Laos (Lao PDR) was investigated for known mutations in CAH associated with salt loss. RESULTS: Molecular genetic diagnosis revealed mutations associated with loss of function in both alleles; however, the infant was clinically unaffected even without any corticosteroid substitution therapy. CONCLUSIONS: Although molecular genetic methods can theoretically predict loss of function in CAH, our infant was clinically unaffected even without therapy at 6 years of age. We speculate that in CAH, remaining enzyme activity can be sufficiently high, despite the presence of loss of function mutations, which do not affect infants clinically.


Assuntos
17-alfa-Hidroxiprogesterona/sangue , Hiperplasia Suprarrenal Congênita/enzimologia , Hiperplasia Suprarrenal Congênita/genética , Mutação/genética , Esteroide 21-Hidroxilase/genética , Hiperplasia Suprarrenal Congênita/sangue , Alelos , Humanos , Recém-Nascido , Laos , Biologia Molecular , Triagem Neonatal , Valor Preditivo dos Testes
2.
J Trop Pediatr ; 59(2): 95-9, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23104563

RESUMO

OBJECTIVES: The People's Democratic Republic of Laos belongs to the minority of countries worldwide without an established newborn bloodspot screening (NBS) system. METHODS: In 2008, we initiated a pilot project of a neonatal screening system in the delivery suites of the Laotian capital, Vientiane. Samples were analysed for thyrotropin-stimulating hormone and 17-hydroxyprogesterone. RESULTS: Altogether 11 362 samples were taken; an initially high recall rate dropped eventually to just above 4%. Two cases of hypothyroidism and one case of congenital adrenal hyperplasia were identified and received timely treatment. CONCLUSIONS: In summary, we have demonstrated the feasibility of establishing an NBS system in a low-resource setting as prevalent in Laos. Obstacles for the establishment of a general NBS covering the whole country include the question of financial cover, treatment costs, and adequate teaching and supervision of technicians and doctors.


Assuntos
17-alfa-Hidroxiprogesterona/sangue , Hiperplasia Suprarrenal Congênita/diagnóstico , Hipotireoidismo Congênito/diagnóstico , Erros Inatos do Metabolismo/sangue , Triagem Neonatal/estatística & dados numéricos , Tireotropina/sangue , Hiperplasia Suprarrenal Congênita/sangue , Hipotireoidismo Congênito/sangue , Estudos de Viabilidade , Humanos , Recém-Nascido , Laos , Masculino , Erros Inatos do Metabolismo/diagnóstico , Triagem Neonatal/organização & administração , Projetos Piloto , Desenvolvimento de Programas , População Urbana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA